Skip to content

The Physical Exercise and Prostate Cancer Study

Physical Exercise for Patients With Prostate Cancer During Androgen Deprivation Therapy - A Randomized Trial

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00658229
Acronym
PEPC
Enrollment
60
Registered
2008-04-14
Start date
2008-11-30
Completion date
2012-05-31
Last updated
2012-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Keywords

Exercise, Prostatic, Neoplasm, Androgen, Deprivation

Brief summary

The purpose of this study is to determine the effectiveness of a four months strength training program on physical and psychological health in patients with prostate cancer during androgen deprivation therapy. It is hypothesized a beneficial effect of the intervention on physical and psychological health in patients with prostate cancer treated with androgen deprivation.

Interventions

After 5-10 months on androgen deprivation therapy the patients in the intervention group go through a four months strength training intervention. The patients will perform three strength-training sessions per week, two under supervision of a sport instructor. Each session will consists of one-three sets of nine strength-training exercises, performed at an intensity of 6 or 10 repetitions of maximum (6-10 RM).

Sponsors

Ullevaal University Hospital
CollaboratorOTHER
Norwegian School of Sport Sciences
CollaboratorOTHER
University of Alberta
CollaboratorOTHER
University of Oslo
CollaboratorOTHER
Norwegian Foundation for Health and Rehabilitation
CollaboratorOTHER
The Royal Norwegian Ministry of Health
CollaboratorOTHER
Oslo University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
No minimum to 75 Years
Healthy volunteers
No

Inclusion criteria

* Newly diagnosed locally advanced prostate cancer (clinical stage T2 and T3) * Referred to RH and UUS for radiotherapy * \< 75 years * Capable of reading and writing Norwegian * Treating oncologist must approve of the subjects' participation * Living within approximately 1 hour from Oslo by car or public transportation

Exclusion criteria

* Routinely resistance training with manuals * Medication for osteoporosis (i.e. bisphosphonates) * Conditions of a severity that contraindicate exercise without adjusted actions * Mentally incompetent conditions * Conditions of a severity that complicates the ability to participate in a supervised training program

Design outcomes

Primary

MeasureTime frame
lean body massbefore ADT, before and after the intervention

Secondary

MeasureTime frame
bone mineral density, fat mass, body mass index, serological outcomes (including lipids, hormones and CRP), physical functioning, psycho-social functioning and muscle cellular outcomes (including muscle fiber size and function)before ADT, before and after the intervention

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 26, 2026